Anebulo Pharmaceuticals I... (ANEB)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

1.40

-3.11%

After-hours Dec 13, 2024, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.

Boring Mode

Year	FY24	FY23	FY22	FY21	FY20
Net Income	-8.20M	-11.73M	-6.83M	-30.25M	-174.64K
Depreciation & Amortization	-	-	-	-	-
Stock-Based Compensation	758.88K	884.72K	480.66K	199.95K	-
Other Working Capital	-421.14K	-153.72K	637.00K	-1.56M	22.58K
Other Non-Cash Items	151.23K	731.01K	209.88K	26.63M	1.29K
Deferred Income Tax	-	-	-	-	-
Change in Working Capital	-799.26K	1.16M	907.78K	-1.45M	22.58K
Operating Cash Flow	-8.09M	-9.68M	-5.44M	-4.87M	-150.77K
Capital Expenditures	-	-	-	-	-
Acquisitions	-	-	-	-	-
Purchase of Investments	-	-	-	-	-
Sales Maturities Of Investments	-	-	-	-	-
Other Investing Acitivies	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Debt Repayment	-	-	-	-201.29K	200.00K
Common Stock Repurchased	-	-	-	-	-
Dividend Paid	-	-	-	-	-
Other Financial Acitivies	-62.35K	-264.68K	-	-821.63K	-
Financial Cash Flow	-62.35K	6.38M	-	21.83M	3.18M
Net Cash Flow	-8.15M	-3.30M	-5.44M	16.96M	3.02M
Free Cash Flow	-8.09M	-9.68M	-5.44M	-4.87M	-150.77K